The Current Ratio as of December 2024 (TTM) for Ascendis Pharma A/S (ASND) is 1.16

According to Ascendis Pharma A/S’s latest financial reports and current stock price. The company's current Current Ratio is 1.16. This represents a change of -26.18% compared to the average of 1.57 of the last 4 quarters.

Ascendis Pharma A/S (ASND) Historical Current Ratio (quarterly & annually)

How has ASND Current Ratio performed in the past?

The mean historical Current Ratio of Ascendis Pharma A/S over the last ten years is 8.87. The current 1.16 Current Ratio has changed 1.21% with respect to the historical average. Over the past ten years (40 quarters), ASND's Current Ratio was at its highest in in the March 2019 quarter at 22.32. The Current Ratio was at its lowest in in the June 2024 quarter at 0.74.

Ascendis Pharma A/S (ASND) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ascendis Pharma A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascendis Pharma A/S (ASND) Average Current Ratio

How has ASND Current Ratio performed in the past?

The current Current Ratio of Ascendis Pharma A/S (ASND) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ascendis Pharma A/S (ASND) Current Ratio vs. Peers

How is ASND’s Current Ratio compared to its peers?

Ascendis Pharma A/S’s Current Ratio is less than Apellis Pharmaceuticals, Inc. (4.36), less than BeiGene, Ltd. (1.93), less than Akero Therapeutics, Inc. (17.25), less than Blueprint Medicines Corporation (3.32), less than Replimune Group, Inc. (10.11), less than Nuvalent, Inc. (23.07), less than Ventyx Biosciences, Inc. (23.52), less than United Therapeutics Corporation (4.58), less than IVERIC bio, Inc. (18.63), less than Amylyx Pharmaceuticals, Inc. (4.55), less than Karuna Therapeutics, Inc. (19.31), less than Day One Biopharmaceuticals, Inc. (14.62), less than Chinook Therapeutics, Inc. (7.59), less than DICE Therapeutics, Inc. (38.14), less than Pliant Therapeutics, Inc. (10.26), less than Crinetics Pharmaceuticals, Inc. (16.38), less than 89bio, Inc. (11.66), less than Madrigal Pharmaceuticals, Inc. (5.98), less than Arcellx, Inc. (4.29), less than Stoke Therapeutics, Inc. (5.09),

Build a custom stock screener for Ascendis Pharma A/S (ASND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascendis Pharma A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascendis Pharma A/S (ASND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascendis Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.